In this video, our analysts discuss a few key dates and events investors should keep an eye on that could cause a recovery in cannabis stocks.

Over the past few months, cannabis stocks have tread lower, with the Horizons Marijuana Life Sciences Index ETF trading near its 52-week lows.

Cannabis sentiment remains poor and has largely been rattled by a vaping health crisis in the U.S. and an announcement by HEXO that they were withdrawing their financial outlook for fiscal 2020.

Despite strong quarterly results by Aphria on October 15, which fuelled a rally in cannabis stocks, it was short-lived, with the rally largely reversing.

Given poor cannabis sentiment, in this report, we have outlined notable earnings dates for investors to watch out for to further gauge outlook on the cannabis market.

Companies such as Canopy, Tilray and Aurora are anticipated to report their quarterly results mid-November.

If quarterly results by these companies are not as bad as the market sees it to be, we believe that cannabis stocks could experience a prolonged rally in the coming weeks.

Despite the poor performance and outlook on the cannabis market, this has not stopped a company, which we discuss in our report, from entering into a LOI to launch a new Canadian cannabis brand to capitalize on the recent legalization of cannabis edibles in Canada.

Click on the link below to access the full report, which also includes updates on companies we cover in the mining and real estate sectors.